Early Detection - Ratner, Bruce; Bonislawski, Adam
26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 2-4 Wochen
payback
13 °P sammeln
  • Gebundenes Buch

"Catching cancer early remains the single best way to combat a disease that is the second-leading killer in both the US and worldwide. But the vast majority of resources in the fight against cancer are devoted to relatively ineffective late stage treatments. Early Detection examines this important anomaly in an accessible and expertly researched survey. In a co-authorship that brings together the passion and urgency of someone touched deeply by the experience of cancer with the knowledge of a skilled science writer, Ratner and Bonislawski narrate compelling case studies across a range of…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
"Catching cancer early remains the single best way to combat a disease that is the second-leading killer in both the US and worldwide. But the vast majority of resources in the fight against cancer are devoted to relatively ineffective late stage treatments. Early Detection examines this important anomaly in an accessible and expertly researched survey. In a co-authorship that brings together the passion and urgency of someone touched deeply by the experience of cancer with the knowledge of a skilled science writer, Ratner and Bonislawski narrate compelling case studies across a range of screening programs and different forms of cancer. They look at the science underpinning early detection and discuss the organizational and social challenges of widespread screening, a dimension that has been shown to be especially important in the COVID-19 pandemic. And they call for the government and the medical establishment to provide resources for expanding screening, especially in economically disadvantaged communities that have traditionally been underserved."--Amazon.com
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
In his long career, Bruce Ratner served as New York City’s Commissioner of Consumer Affairs, an NYU law professor and the founder, chairman, and CEO of Forest City Ratner Companies, a major property developer. He led the economic revival of Downtown Brooklyn, built the Barclays Center arena, brought the Nets NBA basketball franchise to Brooklyn, and helped restore Times Square, including building The New York Times headquarters. For more than two decades, Mr. Ratner has applied his deep interest and background in the sciences by serving on the boards of Weill Cornell Medicine, the Memorial Sloan-Kettering Cancer Center and the Cold Spring Harbor Laboratory. He also founded the Michael D. Ratner Center for Early Detection of Cancer, in memory of his brother, to advance the cause of expanding the adoption of life-saving cancer screening and research into new diagnostic tests. Through the center, Mr. Ratner has promoted early detection testing for lung cancer, particularly in low income and underserved populations. Mr. Ratner is also Chairman of the Museum of Jewish Heritage – A Living Memorial to the Holocaust. He was founding chairman of the New York City Parks Foundation and, for a decade, served as chairman of the board at the Brooklyn Academy of Music. Adam Bonislawskiis a science writer with more than 10 years of experience covering genomic and proteomic research and diagnostics development with a focus on cancer and early detection. His writing ranges widely over academic research, companies and technologies. The publications he writes for, GenomeWeb and 360Dx, are read by thousands of cancer researchers and doctors as well as a wide range of healthcare entrepreneurs and investors, and he has scientific and media contacts at many of the major cancer and academic research centers in the United States and Europe. In addition to his work as a science writer, Adam writes about business and real estate for the Wall Street Journal, New York Post, and Commercial Observer.